GlassScriptPhysician profile
Cynthia A Sloan
NPI 1235117821
$31,822.95
in general payments reported to CMS, 2019-2025
24 companies · $3,069 in 2025
The $3,069 reported for 2025 was more than what 79% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,036 · 2020: $521 · 2021: $9,294 · 2022: $5,117 · 2023: $6,510 · 2024: $5,276 · 2025: $3,069.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $2,006 · Travel and Lodging: $489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,361.00 |
| Food and Beverage | $2,005.78 |
| Travel and Lodging | $488.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $18,051.67 | 2021-2024 | Ubrelvy, Qulipta |
| Livanova USA, INC. | $11,089.93 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator, Vns Therapy |
| Medtronic USA, INC. | $529.49 | 2019 | |
| Emd Serono, INC. | $429.84 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $345.92 | 2019-2020 | |
| Allergan, INC. | $254.26 | 2019-2021 | |
| Ucb, INC. | $238.47 | 2019 | |
| Neuropace, INC. | $124.77 | 2019 | |
| Sk Life Science, INC. | $116.35 | 2020-2021 | |
| Boston Scientific Corporation | $113.00 | 2019-2023 | |
| Lexicon Pharmaceuticals, INC. | $98.58 | 2019 | |
| Genzyme Corporation | $79.13 | 2019-2020 | |
| Lilly USA, LLC | $74.38 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $59.52 | 2019-2020 | |
| Biogen, INC. | $56.75 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Upsher-Smith Laboratories LLC | $29.68 | 2019 | |
| Ge Healthcare | $21.03 | 2019 | |
| Abbott Laboratories | $20.90 | 2019 | |
| Lundbeck LLC | $18.71 | 2020 | |
| Aquestive Therapeutics, INC. | $17.25 | 2020 | |
| Genentech USA, INC. | $16.93 | 2019 | |
| Amgen INC. | $13.40 | 2019 | |
| Acadia Pharmaceuticals INC | $11.88 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $11.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Sloan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.